medline.ch Psychiatrie Schizophrenie und Psychosen

	Unmet Promise or Missed Potential? A pairwise and network meta-analysis on efficacy and safety of metabotropic glutamate receptor agonists and positive allosteric modulators in schizophrenia. J Psychiatr Res Mishra A, Shaju A, Ibrahimpur NS, Mishra BR, Srinivasan A, Maiti R. PMID: 41581301 [PubMed - as supplied by publisher]
	Levels of and changes in psychosis symptoms and clinical insight: Exploring the impact of differential antipsychotic mechanisms. Psychiatry Res Stabell LA, Johnsen E, Kroken R, Løberg EM, Kjelby E, Joa I, Reitan SK, Rettenbacher M, Hugdahl K, Gjestad R. PMID: 41581247 [PubMed - as supplied by publisher]
	Optimizing antipsychotic dosing for relapse prevention in cannabis-induced psychosis: A nationwide cohort study. Psychiatry Res Mustonen A, Niemelä S, Denissoff A, Forti MD, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J, Taipale H. PMID: 41581246 [PubMed - as supplied by publisher]
	Formal thought disorder and familial risk in first-episode psychosis: A study of cortical thickness and neuroimaging-transcriptomic association analysis. Psychiatry Res Neuroimaging Çabuk T, Zhang Y, Palaniyappan L, , Avc, Çakmak IB, Kafal, , O, Toulopoulou T. PMID: 41579632 [PubMed - as supplied by publisher]
	Auditory processing deficits in schizophrenia: Evidence from a novel task. J Psychiatr Res Ma Y, Huang Z, Wang J, Song Y, Wang X, Hao C, Zhang J, Ke D, Ye Z, Ouyang D, Dong W. PMID: 41579455 [PubMed - as supplied by publisher]
	Comparative efficacy and safety of clozapine and olanzapine in schizophrenia and related disorders: An updated systematic review. Psychiatry Res Asenjo-Lobos C, Arancibia M, Cortés-Jofré M, Huang T, Li T, Madrid E, Leucht S. PMID: 41579414 [PubMed - as supplied by publisher]
	The link between GABA levels and P300 abnormalities in schizophrenia spectrum disorders: regional and symptom-based insights. Schizophrenia (Heidelb) Karsl, Meisinger V, Hasanaj G, Kallweit MS, Dengl F, Vural G, Melcher J, Korman M, Klimas N, Schmölz S, , Hisch A, Kr, CDP Working Group, Boudriot E, Moussiopoulou J, Yakimov V, Pogarell O, Schmitt A, Falkai P, Geyer T, Roell L, Wagner E, Raabe FJ, Keeser D. PMID: 41577705 [PubMed - as supplied by publisher]
	Immediate and long-term effects of orbitofrontal cortex stimulation on EEG microstates in schizophrenia. Transl Psychiatry Zhang K, Hu Q, Zhang Y, Zeng N, Wang M, Li K, Wang Z, Sun J, Wang J, Jiao X. PMID: 41577665 [PubMed - as supplied by publisher]
	Social networks and symptomatology in recently hospitalized individuals with schizophrenia-spectrum disorders: A six-month longitudinal study. Psychiatry Res Schock GV, Kittleson AR, Halverson AS, Liu J, Sheffield JM. PMID: 41576489 [PubMed - as supplied by publisher]
	Clinical remission, functional recovery, and employment in early-phase schizophrenia treated with paliperidone palmitate: An 18-month longitudinal Asia-Pacific study. Psychiatry Res Lin CH, Chiang CL, Yu DY, Horio H, Tokushige N, Wu DB. PMID: 41576487 [PubMed - as supplied by publisher]
	Understanding Schizophrenia Through Cultural Lenses in India: A Case Study Using the Cultural Formulation Interview. Issues Ment Health Nurs Ali A, Paul FA, Singh A, Ganie AUR, Dangroo AA. PMID: 41576359 [PubMed - as supplied by publisher]
	Breaking the Negative Symptom Barrier: A Novel Neuromodulation Strategy Using HD-tDCS Primed iTBS in Schizophrenia. J ECT Gupta R, Sharma A, Goyal N. PMID: 41575458 [PubMed - as supplied by publisher]
	Differences and similarities of persons with a diagnosis psychosis or non-psychosis assessed as SMI, among a population of elderly persons in Sweden. Nord J Psychiatry Bülow P, Finkel D, Torgé CJ, Allgurin M, Jegermalm M, Ernsth Bravell M, Bülow PH. PMID: 41575018 [PubMed - as supplied by publisher]
	Overall and Sex-Based Risk Factors for Hyperprolactinemia in Patients With Schizophrenia: A Retrospective Cohort Study. Curr Neuropharmacol Yang Y, Chen X, Liu Z, He H, Li L, Yang M. PMID: 41572773 [PubMed - as supplied by publisher]
	A Dual-Marker Peripheral Signature of IL-6 Elevation and NEAT1 Reduction in Negative-Symptom Schizophrenia: A Cross-Sectional Study. Acta Neuropsychiatr Moga CI, Chiroi PA, Budi, C, Cri, Fadygas-St, Berindan-Neagoe I, Miclu. PMID: 41572421 [PubMed - as supplied by publisher]
	Uncertainty modeling in multimodal speech analysis across the psychosis spectrum. NPJ Digit Med Rohanian M, Hüppi R, Nooralahzadeh F, Dannecker N, Pauli Y, Surbeck W, Sommer I, Hinzen W, Langer N, Krauthammer M, Homan P. PMID: 41571751 [PubMed - as supplied by publisher]
	Effects of a psychoeducation program for relatives of patients with first-episode psychosis who have received psychoeducation: An observational study. Encephale Bouchez M, Andreou Y, Martin J, Vachet V, Franck N, Endomba FT, Chauvet-Gelinier JC. PMID: 41571535 [PubMed - as supplied by publisher]
	Targeting the brain through the nose: Advances in polymeric nanoparticle delivery for schizophrenia. Neuropeptides Ponduri TK, Rao GSNK. PMID: 41570650 [PubMed - as supplied by publisher]
	Reality monitoring across disorders of reality: Systematic and narrative reviews of dissociation and psychosis. J Psychiatr Res Suter G, Apperly I, Zhang L, . PMID: 41570403 [PubMed - as supplied by publisher]
	The impact of gaming on functioning among people with schizophrenia: study protocol for a randomised controlled trial (GAME-A). Trials Välimäki M, Satamo M, Yang M, Vahlberg T. PMID: 41566338 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 67860

Seite 1 von 3393



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung